Ofi Invest Asset Management »

Biogen Idec shares owned by Ofi Invest Asset Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Ofi Invest Asset Management from 13F filings

Historical chart of Ofi Invest Asset Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Ofi Invest Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Ofi Invest Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $23k 115 199.66
2023-09-30 $26k 106 242.75

More positions owned by Ofi Invest Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Caterpillar (CAT)
salesforce (CRM)
Oracle Corporation (ORCL)
Eli Lilly & Co. (LLY)
BlackRock (BLK)
Pepsi (PEP)
UnitedHealth (UNH)

View all positions for Ofi Invest Asset Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec